fig3

Figure 3. Autologous versus allogeneic cellular immunotherapy for canine patients. Autologous products are generated by isolating patient leukocytes through apheresis, expanding and editing the desired subset in the laboratory and reinfusing the edited cells back into the same patient. Allogeneic products are generated from the peripheral blood of a healthy donor and cryopreserved such that they can be available ‘off the shelf’ and administered to unmatched recipients as needed. Created in BioRender. Edmunds, G. (2026) https://BioRender.com/06j6sgf.